Publications (134) JOSÉ LUIS ARIAS MEDIANO publications

2024

  1. A maghemite/PLGA (core/shell) nanostructure that may facilitate chemotherapy and antitumor hyperthermia

    Journal of Magnetism and Magnetic Materials, Vol. 589

2023

  1. (Magnetite/poly(ε-caprolactone))/chitosan (core/shell)/shell nanocomposites with potential applications in hyperthermia cancer therapy

    Journal of Magnetism and Magnetic Materials, Vol. 588

  2. Multi-stimuli-responsive chitosan-functionalized magnetite/poly(ε-caprolactone) nanoparticles as theranostic platforms for combined tumor magnetic resonance imaging and chemotherapy

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 52

  3. pH-dependent, extended release and enhanced in vitro efficiency against colon cancer of Tegafur formulated using chitosan-coated poly(ε-caprolactone) nanoparticles

    Journal of Drug Delivery Science and Technology, Vol. 86

2022

  1. Combined Magnetic Hyperthermia and Photothermia with Polyelectrolyte/Gold-Coated Magnetic Nanorods

    Polymers, Vol. 14, Núm. 22

  2. Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines

    Nanomaterials, Vol. 12, Núm. 3

2021

  1. A tri-stimuli responsive (Maghemite/PLGA)/chitosan nanostructure with promising applications in lung cancer

    Pharmaceutics, Vol. 13, Núm. 8

  2. Aplicación de nanocompuestos core/shell (Fe3O4/PCL) en fototerapia antitumoral

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 162-163

  3. Diseño de nanoestructuras híbridas con potencial aplicación como agentes de contraste T2 en RMI y agentes de hipertermia antitumoral

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 112-114

  4. Engineering of stealth (maghemite/PLGA)/chitosan (core/shell)/shell nanocomposites with potential applications for combined MRI and hyperthermia against cancer

    Journal of Materials Chemistry B, Vol. 9, Núm. 24, pp. 4963-4980

  5. Evaluación de nanoplataformas magnetopoliméricas con potencial aplicación en la teranosis antitumoral

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 21-23

  6. Nanoestructuras (maghemita/PLGA)/quitosano (core/shell)/ shell sensibles al pH y a campos magnéticos, y con actividad frente al cáncer de pulmón

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 109-111

2020

  1. First steps in the formulation of praziquantel nanosuspensions for pharmaceutical applications

    Pharmaceutical Development and Technology, Vol. 25, Núm. 7, pp. 892-898

  2. Gemcitabine-loaded magnetically responsive poly(ε-caprolactone) nanoparticles against breast cancer

    Polymers, Vol. 12, Núm. 12, pp. 1-17

  3. Nanomedicine for vaginal drug delivery

    Theory and Applications of Nonparenteral Nanomedicines (Elsevier), pp. 235-257

  4. Nanotechnology for vaginal drug delivery and targeting

    Nanoengineered Biomaterials for Advanced Drug Delivery (Elsevier), pp. 647-682

2019

  1. An update on liposomes in drug delivery: a patent review (2014-2018)

    Expert Opinion on Therapeutic Patents, Vol. 29, Núm. 11, pp. 891-907

  2. Primeros estudios de preformulación en el desarrollo de una suspensión farmacéutica de micropartículas de Praziquantel destinada a la vía de administración oral

    Ars pharmaceutica, Vol. 60, Núm. 4, pp. 219-225

2018

  1. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy

    Colloids and Surfaces B: Biointerfaces, Vol. 171, pp. 553-565

  2. Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines

    Journal of Pharmacy and Pharmacology, Vol. 70, Núm. 4, pp. 488-497